These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31425161)

  • 1. The Efficacy of Hypnotherapy in the Treatment of Functional Dyspepsia.
    Popa SL; Chiarioni G; David L; Dumitrascu DL
    Am J Ther; 2019; 26(6):e704-e713. PubMed ID: 31425161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypnotherapy for treatment of irritable bowel syndrome.
    Webb AN; Kukuruzovic RH; Catto-Smith AG; Sawyer SM
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005110. PubMed ID: 17943840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Dyspepsia: An Enigma in a Conundrum.
    Romano C; Valenti S; Cardile S; Benninga MA
    J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):579-584. PubMed ID: 27437927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypnotherapy for functional gastrointestinal disorders.
    Drug Ther Bull; 2005 Jun; 43(6):45-8. PubMed ID: 15966557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiological Abnormalities in Functional Dyspepsia Subgroups According to the Rome III Criteria.
    Vanheel H; Carbone F; Valvekens L; Simren M; Tornblom H; Vanuytsel T; Van Oudenhove L; Tack J
    Am J Gastroenterol; 2017 Jan; 112(1):132-140. PubMed ID: 27958284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects and mechanisms of acupuncture and electroacupuncture for functional dyspepsia: A systematic review.
    Guo Y; Wei W; Chen JD
    World J Gastroenterol; 2020 May; 26(19):2440-2457. PubMed ID: 32476804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut-directed hypnotherapy versus standard medical treatment for nausea in children with functional nausea or functional dyspepsia: protocol of a multicentre randomised trial.
    Browne PD; den Hollander B; Speksnijder EM; van Wering HM; Tjon A Ten W; George EK; Groeneweg M; Bevers N; Wessels MMS; van den Berg MM; Goede J; Teklenburg-Roord STA; Frankenhuis C; Benninga MA; Vlieger AM
    BMJ Open; 2019 Apr; 9(4):e024903. PubMed ID: 30975672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot Study of a Self-Administered Hypnosis Intervention for Functional Dyspepsia.
    Kinsinger SW; Joyce C; Venu M; Palsson OS
    Dig Dis Sci; 2022 Jul; 67(7):3017-3025. PubMed ID: 34342754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypnosis Treatment of Gastrointestinal Disorders: A Comprehensive Review of the Empirical Evidence.
    Palsson OS
    Am J Clin Hypn; 2015 Oct; 58(2):134-58. PubMed ID: 26264539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of psychotherapeutic approaches in treatment of functional dyspepsia, systematic review, and meta-analysis.
    Zhang W; Shen Y; Hao J; Zhao Y
    Acta Gastroenterol Belg; 2024; 87(2):294-303. PubMed ID: 39210762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification.
    Suzuki H; Nishizawa T; Hibi T
    J Gastroenterol; 2006 Jun; 41(6):513-23. PubMed ID: 16868798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria.
    Xiao YL; Peng S; Tao J; Wang AJ; Lin JK; Hu PJ; Chen MH
    Am J Gastroenterol; 2010 Dec; 105(12):2626-31. PubMed ID: 20823838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypnotherapy for functional gastrointestinal disorders: a review.
    Miller V; Whorwell PJ
    Int J Clin Exp Hypn; 2009 Jul; 57(3):279-92. PubMed ID: 19459089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of STW 5-II for Functional Dyspepsia Treatment: A Patient Data-Based Meta-Analysis.
    Andresen V; Shah A; Fink C; Rabini S; Wargenau M; Holtmann G
    Digestion; 2024; 105(3):166-174. PubMed ID: 38246134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the evaluation and management of dyspepsia: recent developments and new guidelines.
    Black CJ; Houghton LA; Ford AC
    Therap Adv Gastroenterol; 2018; 11():1756284818805597. PubMed ID: 30397412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-World, Non-Interventional, Observational Study to Evaluate Effectiveness and Tolerability of Acotiamide Hydrochloride Hydrate in Treatment of Functional Dyspepsia.
    Porika SK; Veligandla KC; Muni SK; Acharya S; Mehta SC; Sharma AD
    Adv Ther; 2018 Nov; 35(11):1884-1893. PubMed ID: 30350248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypnosis and Cognitive Behavioral Therapies for the Management of Gastrointestinal Disorders.
    Palsson OS; Ballou S
    Curr Gastroenterol Rep; 2020 Jun; 22(7):31. PubMed ID: 32495233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial Symptoms Felt at the Lower Part of the Epigastrium and a Possible Association of Pancreatic Exocrine Dysfunction with the Pathogenesis of Functional Dyspepsia.
    Fujikawa Y; Tominaga K; Tanaka F; Kamata N; Yamagami H; Tanigawa T; Watanabe T; Fujiwara Y; Arakawa T
    Intern Med; 2017; 56(13):1629-1635. PubMed ID: 28674349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The latent structure of the functional dyspepsia symptom complex: a taxometric analysis.
    Van Oudenhove L; Jasper F; Walentynowicz M; Witthöft M; Van den Bergh O; Tack J
    Neurogastroenterol Motil; 2016 Jul; 28(7):985-93. PubMed ID: 27339217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and emerging therapeutic options for the management of functional dyspepsia.
    Vandenberghe A; Schol J; Van den Houte K; Masuy I; Carbone F; Tack J
    Expert Opin Pharmacother; 2020 Feb; 21(3):365-376. PubMed ID: 31899982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.